Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
68Ga-NEB PET/CT in Healthy Volunteers and Patients
NCT02496013Phase 1Unknown
- Sponsor
- Peking Union Medical College Hospital
- Start
- Jan 2014
- Primary completion
- Dec 2017
- Modality
- Radiopharmaceutical
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of 68Ga-NOTA-Evans Blue, sponsored by Peking Union Medical College Hospital. Primary endpoint: Biodistribution of 68Ga-NEB at 1 year. Status: unknown.
02
Drugs
68Ga-NOTA-Evans Blue
Beyond the preview
Go deeper on NCT02496013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02496013.